Long‐term follow‐up of a prospective, double‐blind, placebo‐controlled randomized trial of clodronate in multiple myeloma
Oral clodronate (1600 mg/d) has been shown to significantly reduce the incidence of skeletal complications in multiple myeloma. Preliminary analysis of a double‐blind placebo‐controlled trial of this treatment indicated that clodronate might prolong survival in patients without vertebral fractures a...
Saved in:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2001
|
| 在线阅读: | https://doi.org/10.1046/j.1365-2141.2001.02851.x https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2141.2001.02851.x |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|